NeuroSpectrum Insights, Inc. (NSIH)
NeuroSpectrum Insights will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
3,750,000
Deal Size
$16.88M
Company Description
NeuroSpectrum Insights is a medical device company preparing to commercialize breakthrough computerized analysis technology that enhances clinicians’ capabilities in diagnosing neurological and neurodevelopmental disorders.
NSI’s first product, GyriCalc™ is a proprietary, patented software solution specifically designed to assist in the diagnosis of autism by identifying early structural markers of neurodevelopmental differences through the automated measurement and analysis of MRI images.
NSI’s initial market focus will be the United States and Canada.
NeuroSpectrum Insights, Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Andrew Stewart |
Contact Details
Address: 367 Main Street, Ste. 105 Bedminster, NJ 07921 United States | |
| Phone | 908-304-4858 |
| Website | neurospectruminsights.com |
Stock Details
| Ticker Symbol | NSIH |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 2034588 |
| Employer ID | 83-1708919 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Andrew Stewart | Chief Executive Officer, Director |
| Joerg Klaube | Chief Financial Officer |
| Mark Rosenberg | Chairman |
| Boura Ali | Director |
| Jason Pottinger | Director |
| Corey Park | Director |